BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17592265)

  • 1. Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathologic characteristics.
    Yamamoto S; Tsuda H; Yoshikawa T; Kudoh K; Kita T; Furuya K; Tamai S; Matsubara O
    Am J Surg Pathol; 2007 Jul; 31(7):999-1006. PubMed ID: 17592265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway.
    Yamamoto S; Tsuda H; Takano M; Hase K; Tamai S; Matsubara O
    J Pathol; 2008 Sep; 216(1):103-10. PubMed ID: 18600856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases.
    Veras E; Mao TL; Ayhan A; Ueda S; Lai H; Hayran M; Shih IeM; Kurman RJ
    Am J Surg Pathol; 2009 Jun; 33(6):844-53. PubMed ID: 19342944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1α, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma.
    Kato M; Yamamoto S; Takano M; Matsubara O; Furuya K
    Int J Gynecol Pathol; 2012 May; 31(3):254-63. PubMed ID: 22498943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clear cell adenocarcinoma with a component of poorly differentiated histology: a poor prognostic subgroup of ovarian clear cell adenocarcinoma.
    Yamamoto S; Tsuda H; Shimazaki H; Takano M; Yoshikawa T; Kuzuya K; Tsuda H; Kurachi H; Kigawa J; Kikuchi Y; Sugiyama T; Matsubara O
    Int J Gynecol Pathol; 2011 Sep; 30(5):431-41. PubMed ID: 21804390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
    Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
    Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways.
    Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
    Virchows Arch; 2009 Nov; 455(5):413-22. PubMed ID: 19855998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary.
    Mizuno M; Kikkawa F; Shibata K; Kajiyama H; Ino K; Kawai M; Nagasaka T; Nomura S
    J Surg Oncol; 2006 Aug; 94(2):138-43. PubMed ID: 16847906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative activity of early ovarian clear cell adenocarcinoma depends on association with endometriosis.
    Komiyama S; Aoki D; Katsuki Y; Nozawa S
    Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):130-6. PubMed ID: 16442693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell carcinomas of the ovary: a multi-institutional study of 129 cases in Korea with prognostic significance of Emi1 and Galectin-3.
    Min KW; Park MH; Hong SR; Lee H; Kwon SY; Hong SH; Joo HJ; Park IA; An HJ; Suh KS; Oh HK; Yoo CW; Kim MJ; Chang HK; Jun SY; Yoon HK; Chang ED; Kim DW; Kim I;
    Int J Gynecol Pathol; 2013 Jan; 32(1):3-14. PubMed ID: 23202783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological grading of ovarian clear cell adenocarcinoma: proposal for a simple and reproducible grouping system based on tumor growth architecture.
    Yamamoto S; Tsuda H; Shimazaki H; Takano M; Yoshikawa T; Kuzuya K; Tsuda H; Kurachi H; Kigawa J; Kikuchi Y; Sugiyama T; Matsubara O
    Int J Gynecol Pathol; 2012 Mar; 31(2):116-24. PubMed ID: 22317866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovarian clear cell adenofibromatous tumor: report of 2 cases].
    Tsurunaga T; Iwai E; Okamoto Y; Ueda M; Yanagawa Y; Okamura S; Ueki M; Sugimoto O; Tanaka H; Yoshikawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jan; 44(1):105-8. PubMed ID: 1541853
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary.
    Sekiya R; Kajiyama H; Sakai K; Umezu T; Mizuno M; Shibata K; Yamamoto E; Fujiwara S; Nagasaka T; Kikkawa F
    Hum Pathol; 2012 Jun; 43(6):904-10. PubMed ID: 22169254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
    Gallardo A; Prat J
    Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma.
    Morita A; Miyagi E; Yasumitsu H; Kawasaki H; Hirano H; Hirahara F
    Proteomics; 2006 Nov; 6(21):5880-90. PubMed ID: 17022098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group.
    Yamamoto S; Kasajima A; Takano M; Yaegashi N; Fujiwara H; Kuzuya K; Kigawa J; Tsuda H; Kurachi H; Kikuchi Y; Sugiyama T; Tsuda H; Moriya T
    Int J Gynecol Pathol; 2011 Mar; 30(2):129-38. PubMed ID: 21293288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
    Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic significance of cyclin D3 in ovarian adenocarcinomas.
    Levidou G; Korkolopoulou P; Thymara I; Vassilopoulos I; Saetta AA; Gakiopoulou H; Konstantinidou A; Kairi-Vassilatou E; Pavlakis K; Patsouris E
    Int J Gynecol Pathol; 2007 Oct; 26(4):410-7. PubMed ID: 17885491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
    Sangoi AR; Soslow RA; Teng NN; Longacre TA
    Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.